CDX2 and colonic neoplasm: By overexpressing CDX2 using an hTERT (hypoxia-inducible human telomerase reverse transcriptase) promoter-driven plasmid, colon cancer cells were prevented from progressing malignantly (Al-Duhaidahawi., 2023).